Cathay Pacific Airways (HK:0293) posted a slight increase in annual profit for 2024, fueled by strong travel demand but tempered by rising costs and normalizing ticket prices.
The airline reported a 1% year-on-year profit rise to HK$9.89 billion ($1.27 billion), up from HK$9.79 billion. Revenue climbed 10.5% to HK$104.37 billion, supported by an 11.9% surge in passenger revenue and an 8.3% increase in cargo revenue.
Despite the revenue boost, Cathay’s profit margin slipped to 9.5% from 10.4%, reflecting higher operational costs and an 11.8% drop in passenger yields as ticket prices stabilized.
Shares edged up 0.5% to HK$11.16, approaching their highest level since May 2019. The airline credited its performance to sustained demand and operational efficiency but remains cautious about macroeconomic uncertainties and trade tensions that could impact future travel.
Cathay declared a second interim dividend of HK$0.49 per share and expects further growth in 2025 as flight operations return to pre-pandemic levels and fleet renewal investments continue.


Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Instagram Outage Disrupts Thousands of U.S. Users
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 



